Antibiotic penetration into lung tissues.
作者信息
Honeybourne D
出版信息
Thorax. 1994 Feb;49(2):104-6. doi: 10.1136/thx.49.2.104.
Abstract
摘要
相似文献
1
Antibiotic penetration into lung tissues.
Thorax. 1994 Feb;49(2):104-6. doi: 10.1136/thx.49.2.104.
2
Penetration of minocycline hydrochloride into lung tissue and sputum.
Chemotherapy. 2001 Jan-Feb;47(1):1-9. doi: 10.1159/000048494.
3
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
J Antimicrob Chemother. 2008 Apr;61(4):859-68. doi: 10.1093/jac/dkn059. Epub 2008 Feb 27.
4
The site concentrations of antimicrobial agents in the lung.
J Antimicrob Chemother. 1992 Sep;30(3):249-60. doi: 10.1093/jac/30.3.249.
5
Antibiotic pharmacokinetic considerations in pulmonary infections.
Semin Respir Infect. 1991 Sep;6(3):168-82.
6
Relation between amoxicillin concentration in sputum of COPD patients and length of hospitalization.
COPD. 2011 Apr;8(2):66-70. doi: 10.3109/15412555.2011.558863.
7
[Kinetics of antibiotic distribution in the bronchopulmonary area].
Rev Pneumol Clin. 1996;52 Suppl 2:S43-6.
8
Pulmonary disposition of antimicrobial agents: methodological considerations.
Antimicrob Agents Chemother. 1992 Jun;36(6):1171-5. doi: 10.1128/AAC.36.6.1171.
9
Pharmacokinetics of antibiotics in the lungs.
Eur Respir J. 1990 Jun;3(6):715-22.
10
[Bronchopulmonary aminochlorthenoxycycline levels in experimental burns of the respiratory tree].
Arch Sci Med (Torino). 1973 Apr-Jun;130(2):151-3.
引用本文的文献
1
Management Strategies for Chronic Suppurative Otitis Media and Why They Fail.
J Assoc Res Otolaryngol. 2025 Jun 16. doi: 10.1007/s10162-025-00996-z.
2
Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling.
Front Microbiol. 2024 Oct 7;15:1435906. doi: 10.3389/fmicb.2024.1435906. eCollection 2024.
3
Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery.
Respir Res. 2022 Dec 24;23(1):376. doi: 10.1186/s12931-022-02299-w.
4
Synergistic effect of low-frequency ultrasound and antibiotics on the treatment of Klebsiella pneumoniae pneumonia in mice.
Microb Biotechnol. 2022 Nov;15(11):2819-2830. doi: 10.1111/1751-7915.14134. Epub 2022 Aug 24.
5
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians.
Pharmaceuticals (Basel). 2022 Apr 12;15(4):463. doi: 10.3390/ph15040463.
6
Comparison of oral, nebulized and combination antibiotic treatment of Bordetella bronchiseptica in baboons (Papio spp.).
J Vet Pharmacol Ther. 2021 Sep;44(5):836-841. doi: 10.1111/jvp.12975. Epub 2021 May 8.
7
Deaths Associated with Pneumonic Plague, 1946-2017.
Emerg Infect Dis. 2020 Oct;26(10):2432-2434. doi: 10.3201/eid2610.191270.
8
Effect of an antimicrobial drug on lung microbiota in healthy dogs.
Heliyon. 2019 Nov 14;5(11):e02802. doi: 10.1016/j.heliyon.2019.e02802. eCollection 2019 Nov.
9
Biological Obstacles for Identifying - Correlations of Orally Inhaled Formulations.
Pharmaceutics. 2019 Jul 5;11(7):316. doi: 10.3390/pharmaceutics11070316.
10
Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future.
ACS Infect Dis. 2018 Oct 12;4(10):1439-1447. doi: 10.1021/acsinfecdis.8b00160. Epub 2018 Sep 10.
本文引用的文献
1
Lung distribution and pharmacokinetics of aerosolized tobramycin.
Am Rev Respir Dis. 1993 May;147(5):1279-82. doi: 10.1164/ajrccm/147.5.1279.
2
Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
Respir Med. 1993 Nov;87(8):595-601. doi: 10.1016/s0954-6111(05)80262-8.
3
Plasma and sputum erythromycin concentrations in chronic bronchitis.
Thorax. 1980 Jun;35(6):441-5. doi: 10.1136/thx.35.6.441.
4
Penetration of antibiotics into the respiratory tree.
J Antimicrob Chemother. 1981 Sep;8(3):171-4. doi: 10.1093/jac/8.3.171.
5
Antibiotic entry into human polymorphonuclear leukocytes.
Antimicrob Agents Chemother. 1982 Mar;21(3):373-80. doi: 10.1128/AAC.21.3.373.
6
Membrane transport of clindamycin in alveolar macrophages.
Antimicrob Agents Chemother. 1982 Feb;21(2):241-7. doi: 10.1128/AAC.21.2.241.
7
Penetration of antibiotics into respiratory secretions.
Rev Infect Dis. 1981 Jan-Feb;3(1):67-73. doi: 10.1093/clinids/3.1.67.
8
Uptake of antibiotics by human alveolar macrophages.
Am Rev Respir Dis. 1984 Jun;129(6):933-7. doi: 10.1164/arrd.1984.129.6.933.
9
Penetration of cefaclor into bronchial mucosa.
Thorax. 1984 Nov;39(11):813-7. doi: 10.1136/thx.39.11.813.
10
The use of combinations of trimethoprim and sulphonamides in the treatment of chest infections.
J Antimicrob Chemother. 1983 Nov;12(5):423-34. doi: 10.1093/jac/12.5.423.
Zotero 插件